New personalized Vaccine-Like therapy takes on deadly brain cancer
Disease control
Ongoing
This phase 2b trial tests IGV-001, a personalized immunotherapy made from each patient's own tumor cells, for newly diagnosed glioblastoma. About 93 participants receive either IGV-001 or a placebo, along with standard radiation and chemotherapy. The goal is to see if the treatme…
Phase: PHASE2 • Sponsor: Imvax • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC